Literature DB >> 17249275

Adenocarcinoma of the esophago-gastric junction.

J R Siewert1, H J Stein, M Feith.   

Abstract

BACKGROUND: The border between the esophagus and stomach gives rise to many discrepancies in the current literature regarding the etiology, classification and surgical treatment of adenocarcinoma arising at the esophago-gastric junction. We have consequently used the AEG-criteria (adenocarcinoma of the esophago-gastric junction) for classification and have based the selection of the surgical approach on the anatomic topographic subclassification.
METHODS: In the following we report an analysis of a large and homogeneously classified population of 1602 consecutive patients with adenocarcinoma of the esophago-gastric junction, with an emphasis on the surgical approach, the pattern of lymphatic spread, the outcome after surgical treatment and the prognostic factors. Demographic data, morphologic and histopathologic tumor characteristics, and long-term survival rates were compared among the three tumor subclassifiations.
RESULTS: The study confirms the marked differences in sex distribution, associated specialized intestinal metaplasia in the esophagus, tumor grading, tumor growth pattern, lymphatic spread, and stage between the three tumor entities. The degree of resection and lymph node status were the dominating independent prognostic factors by multivariate analysis. The data show no significant differences of long-term survival after abdomino-thoracic esophagectomy and extended total gastrectomy in these patients.
CONCLUSION: The classification of adenocarcinomas of the esophago-gastric junction in three types, AEG type I, type II and type III shows marked differences between the tumor entities and is recommended for selection of a proper surgical approach. Complete tumor resection and adequate lymphadenectomy are associated with good long-term prognosis. Better surgical management and standardized procedures will improve the outcome also of patients who need to undergo more radical surgery, i.e. abdomino-thoracic esophagectomy.

Entities:  

Mesh:

Year:  2006        PMID: 17249275     DOI: 10.1177/145749690609500409

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  30 in total

Review 1.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

Review 2.  Updating controversies on the multidisciplinary management of gastric cancer.

Authors:  Javier Lacueva; Javier Gallego; Juan Antonio Díaz-González
Journal:  Clin Transl Oncol       Date:  2010-10       Impact factor: 3.405

Review 3.  Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.

Authors:  Kei Hosoda; Keishi Yamashita; Natusya Katada; Masahiko Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-08-01

Review 4.  Current practice for gastric cancer treatment in Ukraine.

Authors:  Andrii Sydiuk
Journal:  Transl Gastroenterol Hepatol       Date:  2017-05-16

5.  Lymph node metastasis in gastric cardiac adenocarcinoma in male patients.

Authors:  Gang Ren; Ying-Wei Chen; Rong Cai; Wen-Jie Zhang; Xiang-Ru Wu; Ye-Ning Jin
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

6.  Clinicopathologic Characteristics of Barrett's Cancer in Korea.

Authors:  Jun-Won Chung; Gin Hyug Lee; Hwoon-Yong Jung; Kee Don Choi; Ho June Song; Kwi-Sook Choi; Hyung Chul Oh; Kee Wook Jung; Jae Won Choe; Jeong Won Kim; Eunsil Yu; Jin-Ho Kim
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

7.  Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population.

Authors:  Farzaneh Karimi; Seyedeh Mina Amiri-Moghaddam; Zakieh Bagheri; Ahmad Reza Bahrami; Ladan Goshayeshi; Abolghasem Allahyari; Marjane Mirsadraee; Azar Fanipakdel; Alireza Bari; Ali Emadi-Torghabeh; Mohammad Amin Kerachian; Hossein Rahimi; Maryam M Matin
Journal:  Mol Biol Rep       Date:  2021-03-13       Impact factor: 2.316

8.  Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.

Authors:  Mimi C Tan; Nabil Mansour; Donna L White; Amy Sisson; Hashem B El-Serag; Aaron P Thrift
Journal:  Aliment Pharmacol Ther       Date:  2020-05-26       Impact factor: 8.171

9.  Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.

Authors:  Yi-Fen Zhang; Jiong Shi; Hui-Ping Yu; An-Ning Feng; Xiang-Shan Fan; Gregory Y Lauwers; Hiroshi Mashimo; Jason S Gold; Gang Chen; Qin Huang
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 10.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.